TPST
TPST
NASDAQ · Biotechnology

Tempest Therapeutics Inc

$1.02
-0.16 (-13.25%)
As of Aug 14, 10:22 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,207.4% upside
Low Target $35.70
Average Target $43.72
High Target $58.20
Current Price $1.02
Current
$1.02
Target
$43.72
$35.70 $43.72 avg $58.20
Scenario Analysis
Bear Case
$35.70
3,417.2%
Low target
Base Case
$43.72
+4,207.4%
Avg target
Bull Case
$58.20
+5,634.0%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$12.23
-91.7% from high
52-Week Low
$0.84
+20.8% from low
Target vs 52W High
$43.72
+257.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%